G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.60
+0.70 (1.35%)
Apr 24, 2025, 1:20 PM CST
-4.52%
Market Cap 3.06B
Revenue (ttm) 249.03M
Net Income (ttm) 102.06M
Shares Out 59.00M
EPS (ttm) 1.73
PE Ratio 30.00
Forward PE n/a
Dividend 0.76 (1.49%)
Ex-Dividend Date n/a
Volume 5,875
Average Volume 29,328
Open 51.70
Previous Close 51.90
Day's Range 51.70 - 52.60
52-Week Range 45.00 - 61.70
Beta -0.66
RSI 48.47
Earnings Date May 8, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 39
Stock Exchange Taipei Exchange
Ticker Symbol 4911
Full Company Profile

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.

Financial Statements

News

There is no news available yet.